Q2 2026 analysis shows expanding approvals, stronger uptake, and a shift toward evidence-driven biosimilar evaluation
The first Phase III and second Phase III trials will be multi-centre, randomised, assessor-blind, active-comparator studies to determine the efficacy, safety and tolerability of orally administered Zintrodiazine
New appointments bring diagnostics and medtech expertise to strengthen healthcare delivery and policy engagement
As part of the partnership, Boehringer Ingelheim will provide access to its opnMe® platform, enabling broader scientific exchange and driving innovation-led research.
These findings help explain how relapse-triggering memories can persist alongside those that support recovery
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
Medical experts point to a growing body of research linking energy drinks to liver injury
Move to accelerate cancer care expansion across India
Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits
The grant backed by Novartis to strengthen academia-industry collaboration across all seven NIPERs
Subscribe To Our Newsletter & Stay Updated
